Inflammatory Bowel Disease Nutrition

Inflammatory bowel disease (IBD) comprises chronic, relapsing inflammatory disorders of the gastrointestinal tract, principally Crohn's disease and ulcerative colitis. Nutrition is central to IBD because intestinal inflammation, reduced intake, malabsorption, and increased losses combine to make malnutrition and specific deficiencies common, while diet and nutrition support are part of disease management, particularly in Crohn's disease.

Definition

Inflammatory bowel disease nutrition is the assessment and management of nutritional status in Crohn's disease and ulcerative colitis, chronic immune-mediated inflammatory disorders of the gut in which inflammation, malabsorption, and altered metabolism produce malnutrition and micronutrient deficiency.

Scope

This topic covers IBD as a clinical entity within gastrointestinal and liver nutrition, focusing on why these inflammatory disorders impair nutritional status and how nutrition is positioned in their care. It frames the mechanisms of IBD-related malnutrition, the deficiencies that characteristically accompany Crohn's disease and ulcerative colitis, and the evidence-based role of nutritional support as reference knowledge, not individualised dietary prescription.

Core questions

• How do chronic intestinal inflammation and its complications produce malnutrition in IBD?
• Which nutrient deficiencies characteristically accompany Crohn's disease and ulcerative colitis?
• What is the evidence base for nutrition support, including exclusive enteral nutrition in Crohn's disease?
• How is nutritional risk screened and assessed in patients with IBD?

Key concepts

• Crohn's disease and ulcerative colitis
• Disease-related malnutrition
• Exclusive enteral nutrition
• Iron-deficiency anaemia
• Vitamin B12 and folate deficiency
• Sarcopenia
• Intestinal inflammation and increased nutrient losses
• Nutritional screening in chronic disease

Mechanisms

Malnutrition in IBD arises from several converging mechanisms: chronic inflammation raises energy expenditure and promotes muscle catabolism; symptoms such as pain, nausea, and diarrhoea reduce oral intake; mucosal inflammation and, in Crohn's disease, small-bowel involvement or resection impair absorption; and inflamed or ulcerated bowel increases protein and micronutrient losses. The pattern of deficiency depends on disease location, so ileal Crohn's disease may impair vitamin B12 and bile-salt handling, while chronic blood loss contributes to iron deficiency. In active Crohn's disease, exclusive enteral nutrition can both supply nutrition and reduce inflammation, and structured nutritional screening and support are recommended across IBD (Forbes 2017). Medical therapy that controls inflammation is itself an indirect determinant of nutritional recovery (Burr 2021).

Clinical relevance

Malnutrition, micronutrient deficiency, and sarcopenia are frequent in IBD and are associated with worse outcomes, so nutritional status is a recognised part of overall assessment. Understanding the mechanisms clarifies why nutrition support, and in Crohn's disease enteral nutrition, has a defined role alongside medical therapy. This entry is reference material on the nutritional dimension of IBD and is not a substitute for individualised clinical or dietary management.

Epidemiology

Nutritional risk is common in IBD, with malnutrition and deficiencies such as iron and vitamin B12 reported across patient populations, and prevalence varying with disease activity, extent, and prior surgery. The ESPEN IBD guideline summarises this nutritional burden and the basis for routine screening (Forbes 2017).

History

The recognition that IBD is regularly accompanied by malnutrition grew alongside the characterisation of Crohn's disease and ulcerative colitis as distinct chronic inflammatory disorders in the twentieth century. The observation that exclusive enteral nutrition could induce remission in Crohn's disease established nutrition as a therapeutic tool, and dedicated clinical-nutrition guidelines later consolidated the field by setting out screening, assessment, and support across IBD (Forbes 2017). Advances in anti-inflammatory medical therapy reshaped the context in which nutritional management operates (Burr 2021).

Debates

What is the role of dietary therapy versus drug therapy in inducing remission?

Exclusive enteral nutrition can induce remission in Crohn's disease, particularly in children, yet its place relative to expanding biological and small-molecule drug options, and the evidence for specific solid-food diets, remains an area of active discussion.

Seminal works

• forbes-2017
• burr-2021

Frequently asked questions

Why is malnutrition so common in inflammatory bowel disease?

Chronic intestinal inflammation raises metabolic demand and promotes muscle loss, while symptoms reduce intake, inflamed or resected bowel impairs absorption, and ulcerated mucosa increases nutrient and protein losses, so malnutrition and specific deficiencies are frequent.

Can nutrition be used to treat Crohn's disease, not just support it?

In Crohn's disease, exclusive enteral nutrition can be used to induce remission as well as to provide nutrition, which is one reason nutrition has a defined therapeutic role in this condition; the details of when and how are matters for clinical guidelines and individualised care.